N/A
Completed N=11
Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy
Acne Keloidalis Nuchae
Source: ClinicalTrials.gov NCT01328080 ↗
Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Jun 2014
Primary outcomePrimary: Percentage Change in Total AKN Lesions From Baseline to Week 16. — 49 percentage of lesion count reduction
Summary
This study is being done to evaluate the effect of targeted UV-B (a component of sunlight) on the treatment of acne keloidalis nuchae (AKN, or razor bumps on the back of the neck). The investigators believe targeted UV-B is a safe and effective way to reduce the appearance of AKN.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage Change in Total AKN Lesions From Baseline to Week 16. |
49 | — |
Eligibility Criteria
Inclusion Criteria
- age 18 or over
- male gender
- African-American or other black ethnicity
- current diagnosis of acne keloidalis nuchae (razor bumps on back of neck)
Exclusion Criteria
- allergy to lidocaine or numbing medicine
- history of increased sensitivity to sunlight, lupus, or porphyria
- current use of a drug that increases sensitivity to sunlight
Data sourced from ClinicalTrials.gov (NCT01328080). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.